Adherence to New Oral Anticoagulation Therapy in Turkey
NCT02480920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2738
Last updated 2019-04-09
Summary
This study will compose a national database of drug adherence and investigate the factors that affect drug adherence in patients taking new oral anticoagulation therapy in Turkish Population.
Conditions
Sponsors & Collaborators
-
Cardiovascular Academy Society, Turkey
lead OTHER
Principal Investigators
-
Volkan Emren, MD · Cardiovascular Academy Society, İzmir, Turkey
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-04-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Assessment of The Effect of Apixaban in AF
NCT03199521 ·Status: COMPLETED
-
Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)
NCT03568916 ·Status: COMPLETED
-
A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation
NCT05232643 ·Status: RECRUITING
-
Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey
NCT03601013 ·Status: COMPLETED
-
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
NCT02921126 ·Status: COMPLETED
-
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913 ·Status: UNKNOWN
-
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
NCT04099238 ·Status: COMPLETED
-
Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation
NCT02082548 ·Status: COMPLETED ·Phase: NA
-
Treatment Pattern of Oral Anticoagulants (OAC) in Japan
NCT02982863 ·Status: COMPLETED
-
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417 ·Status: RECRUITING ·Phase: PHASE4
-
Atrial Fibrillation Feasibility Certoparin Trial - AFFECT
NCT00171769 ·Status: COMPLETED ·Phase: PHASE3
-
START-Register: Survey on Anticoagulated Patients Register
NCT02219984 ·Status: RECRUITING
-
Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 ·Status: UNKNOWN
-
Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)
NCT00623779 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061 ·Status: UNKNOWN
-
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00412984 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
NCT03126214 ·Status: COMPLETED ·Phase: PHASE4
-
Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia
NCT01361386 ·Status: COMPLETED
-
Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
NCT05438888 ·Status: COMPLETED
-
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
NCT02565693 ·Status: COMPLETED ·Phase: PHASE2
-
Apixaban Dose Reduction in Patients With Elevated Drug Levels
NCT02809469 ·Status: UNKNOWN ·Phase: PHASE2
-
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
NCT02635230 ·Status: UNKNOWN
-
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
NCT01214122 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
NCT00496769 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Function in Patients With an Acute Coronary Syndrome
NCT01992484 ·Status: UNKNOWN